Clinical trial
The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder
NCT00438971 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2006
- Completion date
- January 31, 2009
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.